Related Experiment Videos
Update on psychotropic medication use in renal disease
Lewis M Cohen1, Edward G Tessier, Michael J Germain
1Psychiatri Consultation Service adn Renal Transplantation Service, Baystate Medical Center, Springfield, MA 01199, USA. lewis.cohen@bhs.org
Psychosomatics
|January 8, 2004
Summary
Psychiatric medications are generally safe for patients with renal failure. Most psychotropic drugs are metabolized by the liver and excreted via bile, making them suitable for individuals with end-stage renal disease.
Area of Science:
- Nephrology
- Psychiatry
- Clinical Pharmacology
Background:
- Renal failure frequently co-occurs with psychiatric disorders.
- Consultation psychiatrists require guidance on psychotropic medication use in renal disease.
Purpose of the Study:
- To review pharmacokinetic considerations for psychotropic medications in patients with renal disease.
- To provide information on the safe use of specific psychotropic drugs in this population.
Main Methods:
- Literature review focusing on pharmacokinetic properties of psychotropic drugs.
- Analysis of drug metabolism and excretion pathways relevant to renal impairment.
Main Results:
- Most psychotropic medications are lipophilic, cross the blood-brain barrier readily, and are not removed by dialysis.
- Primary metabolism occurs in the liver, with excretion mainly through bile.
Conclusions:
- The majority of psychotropic medications can be safely administered to patients with end-stage renal disease.
- Understanding drug pharmacokinetics is crucial for safe and effective psychiatric treatment in renal patients.